TIPE3 is a candidate prognostic biomarker promoting tumor progression via elevating RAC1 in pancreatic cancer

Detalles Bibliográficos
Autores principales: Li, Zequn, Cao, Shougen, Sun, Yuqi, Niu, Zhaojian, Liu, Xiaodong, Niu, Jun, Zhou, Yanbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361694/
https://www.ncbi.nlm.nih.gov/pubmed/35941647
http://dx.doi.org/10.1186/s12943-022-01626-5
_version_ 1784764580565614592
author Li, Zequn
Cao, Shougen
Sun, Yuqi
Niu, Zhaojian
Liu, Xiaodong
Niu, Jun
Zhou, Yanbing
author_facet Li, Zequn
Cao, Shougen
Sun, Yuqi
Niu, Zhaojian
Liu, Xiaodong
Niu, Jun
Zhou, Yanbing
author_sort Li, Zequn
collection PubMed
description
format Online
Article
Text
id pubmed-9361694
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-93616942022-08-10 TIPE3 is a candidate prognostic biomarker promoting tumor progression via elevating RAC1 in pancreatic cancer Li, Zequn Cao, Shougen Sun, Yuqi Niu, Zhaojian Liu, Xiaodong Niu, Jun Zhou, Yanbing Mol Cancer Correspondence BioMed Central 2022-08-09 /pmc/articles/PMC9361694/ /pubmed/35941647 http://dx.doi.org/10.1186/s12943-022-01626-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correspondence
Li, Zequn
Cao, Shougen
Sun, Yuqi
Niu, Zhaojian
Liu, Xiaodong
Niu, Jun
Zhou, Yanbing
TIPE3 is a candidate prognostic biomarker promoting tumor progression via elevating RAC1 in pancreatic cancer
title TIPE3 is a candidate prognostic biomarker promoting tumor progression via elevating RAC1 in pancreatic cancer
title_full TIPE3 is a candidate prognostic biomarker promoting tumor progression via elevating RAC1 in pancreatic cancer
title_fullStr TIPE3 is a candidate prognostic biomarker promoting tumor progression via elevating RAC1 in pancreatic cancer
title_full_unstemmed TIPE3 is a candidate prognostic biomarker promoting tumor progression via elevating RAC1 in pancreatic cancer
title_short TIPE3 is a candidate prognostic biomarker promoting tumor progression via elevating RAC1 in pancreatic cancer
title_sort tipe3 is a candidate prognostic biomarker promoting tumor progression via elevating rac1 in pancreatic cancer
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361694/
https://www.ncbi.nlm.nih.gov/pubmed/35941647
http://dx.doi.org/10.1186/s12943-022-01626-5
work_keys_str_mv AT lizequn tipe3isacandidateprognosticbiomarkerpromotingtumorprogressionviaelevatingrac1inpancreaticcancer
AT caoshougen tipe3isacandidateprognosticbiomarkerpromotingtumorprogressionviaelevatingrac1inpancreaticcancer
AT sunyuqi tipe3isacandidateprognosticbiomarkerpromotingtumorprogressionviaelevatingrac1inpancreaticcancer
AT niuzhaojian tipe3isacandidateprognosticbiomarkerpromotingtumorprogressionviaelevatingrac1inpancreaticcancer
AT liuxiaodong tipe3isacandidateprognosticbiomarkerpromotingtumorprogressionviaelevatingrac1inpancreaticcancer
AT niujun tipe3isacandidateprognosticbiomarkerpromotingtumorprogressionviaelevatingrac1inpancreaticcancer
AT zhouyanbing tipe3isacandidateprognosticbiomarkerpromotingtumorprogressionviaelevatingrac1inpancreaticcancer

Ejemplares similares